A number of investment brokers have recently updated their price targets on shares of Natus Medical Incorporated (NASDAQ:BABY). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

04/05/2016 – Natus Medical Incorporated was downgraded to “market perform” by analysts at Raymond James.

04/05/2016 – Natus Medical Incorporated had its “buy” rating reiterated by analysts at Roth Capital. They now have a USD 39 price target on the stock.

01/22/2015 – Natus Medical Incorporated was upgraded to “outperform” by analysts at Zacks. They now have a USD 39 price target on the stock.

10/07/2014 – Natus Medical Incorporated was upgraded to “outperform” by analysts at William Blair.

The share price of Natus Medical Incorporated (NASDAQ:BABY) was down -0.53% during the last day of trading, with a day high of 32.54. 423596 shares were traded during the last session.

The stock’s 50 day moving average is 33.74 and its 200 day moving average is 40.20. The stock’s market capitalization is 1.04B. Natus Medical Incorporated has a 52-week low of 29.34 and a 52-week high of 51.05.

View other investors thoughts on Natus Medical Incorporated with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.